Hormone resistance caused by mutations in G proteins and G protein-coupled receptors
- PMID: 10698594
Hormone resistance caused by mutations in G proteins and G protein-coupled receptors
Abstract
G proteins couple receptors for many hormones to effectors that regulate second messenger metabolism. Several endocrine disorders have been shown to be caused by either loss or gain of function mutations in G proteins or G protein-coupled receptors. Pseudohypoparathyroidism (PHP), the first described example of a hormone resistance disorder, is characterized by renal resistance to parathyroid hormone (PTH) proximal to generation of the second messenger, cAMP. In PHP Ia there is more generalized hormone resistance (PTH, TSH, gonadotropins) and associated abnormal physical features, Albright hereditary osteodystrophy (AHO). Subjects with PHP Ib are normal in appearance and resistant exclusively to PTH. Germline loss of function mutations have been identified in the Gs-alpha gene in PHP Ia, and recent evidence suggests that the Gs-alpha gene is paternally imprinted in a tissue-specific manner. In PHP Ib, several studies have excluded PTH receptor gene mutations, and the molecular basis has not yet been defined.
Similar articles
-
G protein defects in signal transduction.Horm Res. 2000;53 Suppl 3:17-22. doi: 10.1159/000023526. Horm Res. 2000. PMID: 10971097 Review.
-
[Gene abnormality associated with resistance to parathyroid hormone].Clin Calcium. 2001 Dec;11(12):1617-22. Clin Calcium. 2001. PMID: 15775476 Japanese.
-
Two mutations of the Gsalpha gene in two Japanese patients with sporadic pseudohypoparathyroidism type Ia.J Hum Genet. 2001;46(7):426-30. doi: 10.1007/s100380170062. J Hum Genet. 2001. PMID: 11450852
-
Pseudohypoparathyroidism type Ia from maternal but not paternal transmission of a Gsalpha gene mutation.Am J Med Genet. 1998 May 26;77(4):261-7. Am J Med Genet. 1998. PMID: 9600732
-
Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.J Clin Res Pediatr Endocrinol. 2017 Dec 30;9(Suppl 2):58-68. doi: 10.4274/jcrpe.2017.S006. Epub 2017 Dec 27. J Clin Res Pediatr Endocrinol. 2017. PMID: 29280743 Free PMC article. Review.
Cited by
-
Pseudohypoparathyroidism type Ib associated with novel duplications in the GNAS locus.PLoS One. 2015 Feb 24;10(2):e0117691. doi: 10.1371/journal.pone.0117691. eCollection 2015. PLoS One. 2015. PMID: 25710380 Free PMC article.
-
Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.Cancers (Basel). 2019 Oct 10;11(10):1523. doi: 10.3390/cancers11101523. Cancers (Basel). 2019. PMID: 31658655 Free PMC article. Review.
-
Validation of fumonisin biomarkers in F344 rats.Toxicol Appl Pharmacol. 2007 Nov 15;225(1):28-39. doi: 10.1016/j.taap.2007.06.027. Epub 2007 Aug 16. Toxicol Appl Pharmacol. 2007. PMID: 17904604 Free PMC article.
-
Cutaneous nodules and a novel GNAS mutation in a Chinese boy with pseudohypoparathyroidism type Ia: A case report and review of literature.World J Clin Cases. 2020 Feb 6;8(3):587-593. doi: 10.12998/wjcc.v8.i3.587. World J Clin Cases. 2020. PMID: 32110670 Free PMC article.